A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma
Abstract Glioblastoma is a highly aggressive and malignant type of cancer that is apoptosis resistant and difficult to cure by conventional cancer therapies. In this regard, an oncolytic adenovirus that selectively targets the tumour tissue and induces tumour cell lysis is a promising treatment opti...
Guardado en:
Autores principales: | Eonju Oh, JinWoo Hong, Oh-Joon Kwon, Chae-Ok Yun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/803f9446854b41d299ebbd0e7ff06be5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines.
por: Alessia Calzolari, et al.
Publicado: (2014) -
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.
por: Carlos López-Gómez, et al.
Publicado: (2011) -
Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
por: Katsuyuki Aoyama, et al.
Publicado: (2017) - Trail & Landscape
-
On the corruption trail
por: Lynne Amepou
Publicado: (1996)